2,2′-{[2-(2-Hy­droxy­phen­yl)-4-methyl­imidazolidine-1,3-di­yl]bis­(methyl­ene)}diphenol

The asymmetric unit in the title compound, C(24)H(26)N(2)O(3), comprises two independent mol­ecules (A and B). In molecule A, the central 2-hydroxyphenyl ring is inclined to the mean plane of the major component of the imidazolidine ring by 84.52 (14)°, and by 68.08 (9) and 47.48 (9)° to the outer phenol rings. The later are inclined to one another by 66.76 (9)° and by 78.12 (14) and 80.20 (14)° to the imidazoline ring mean plane. In molecule B, the central 2-hydroxyphenyl ring is inclined to the mean plane of the imidazolidine ring by 73.64 (10)°, and by 75.60 (8) and 38.32 (9)° to the outer phenol rings. The later are inclined to one another by 69.47 (9)° and by 82.60 (10) and 64.26 (10)° to the imidazolidine ring mean plane. In each of the independent mol­ecules, two intra­molecular O—H⋯N hydrogen bond form S(6) ring motifs. In disordered mol­ecule A, the O—H groups of the 2-hy­droxy­benzyl groups are also involved in intra­molecular O—H⋯O hydrogen bonds, with the O atom of the hy­droxy­phenyl group acting as the acceptor. In the crystal, A molecules are linked by pairs of O—H⋯O hydrogen bonds forming inversion dimers. These dimers are linked to the B molecules via O—H⋯O hydrogen bonds forming double-layered slabs lying parallel to the bc plane.